|
interferon regulatory factor 3-interferon regulatory factor 7 complex
|
GO_0097075 |
[An interferon regulatory factor complex that consists of a heterodimer of interferon regulatory factor 3 and interferon regulatory factor 7.] |
|
transforming growth factor beta activated kinase 1 complex
|
GO_0097076 |
[A protein complex that possesses protein kinase activity and activates the I-kappa B kinase complex (IKK) and mitogen-activated protein (MAP) kinases in response to TRAF6 signaling. It comprises the catalytic subunit TAK1 complexed to the regulatory subunits, termed TABs (TAK1-binding subunits).] |
|
copper ion sensor activity
|
GO_0097077 |
[Binding to and responding, e.g. by conformational change, to changes in the cellular level of copper(I) (Cu+).] |
|
FAL1-SGD1 complex
|
GO_0097078 |
[A protein complex involved in the 18S rRNA biogenesis. In S. cerevisiae this complex consists of Fal1p and Sgd1p and in humans this complex consists of NOM1 and eIF4AIII subunits.] |
|
selenite:proton symporter activity
|
GO_0097079 |
[Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: selenite(out) + H+(out) = selenite(in) + H+(in).] |
|
regulation of the velocity of shortening of skeletal muscle modulating contraction
|
GO_0014729 |
[Any process that modulates velocity of shortening of a skeletal muscle contraction. The shortening leads to reduction of the length of muscle fibers and sarcomeres.] |
|
positive regulation of extraocular skeletal muscle development
|
GO_0014727 |
[Any process that activates, maintains or increases the frequency, rate or extent of extraocular skeletal muscle development. Extraocular skeletal muscle development is the process whose specific outcome is the progression of the extraocular skeletal muscle over time, from its formation to the mature structure. The extraocular muscle is derived from cranial mesoderm and controls eye movements. The muscle begins its development with the differentiation of the muscle cells and ends with the mature muscle.] |
|
regulation of extraocular skeletal muscle development
|
GO_0014725 |
[Any process that modulates the frequency, rate or extent of extraocular skeletal muscle development. Extraocular skeletal muscle development is the process whose specific outcome is the progression of the extraocular skeletal muscle over time, from its formation to the mature structure. The extraocular muscle is derived from cranial mesoderm and controls eye movements. The muscle begins its development with the differentiation of the muscle cells and ends with the mature muscle.] |
|
regulation of the force of skeletal muscle contraction
|
GO_0014728 |
[Any process that modulates the frequency, rate or extent of the force of skeletal muscle contraction. The force of skeletal muscle contraction is produced by acto-myosin interaction processes through the formation of cross bridges.] |
|
negative regulation of extraocular skeletal muscle development
|
GO_0014726 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of extraocular skeletal muscle development. Extraocular skeletal muscle development is the process whose specific outcome is the progression of the extraocular skeletal muscle over time, from its formation to the mature structure. The extraocular muscle is derived from cranial mesoderm and controls eye movements. The muscle begins its development with the differentiation of the muscle cells and ends with the mature muscle.] |
|
skeletal muscle hypertrophy
|
GO_0014734 |
[The enlargement or overgrowth of all or part of an organ due to an increase in size (not length) of individual muscle fibers without cell division. In the case of skeletal muscle cells this happens due to the additional synthesis of sarcomeric proteins and assembly of myofibrils.] |
|
skeletal muscle adaptation
|
GO_0043501 |
[Any process in which skeletal muscles change their phenotypic profiles in response to altered functional demands and a variety of signals.] |
|
regulation of muscle atrophy
|
GO_0014735 |
[Any process that modulates the frequency, rate or extent of muscle atrophy.] |
|
skeletal muscle atrophy
|
GO_0014732 |
[A process, occurring in skeletal muscle, that is characterized by a decrease in protein content, fiber diameter, force production and fatigue resistance in response to different conditions such as starvation, aging and disuse.] |
|
plasma membrane selenite transport
|
GO_0097080 |
[The directed movement of inorganic selenite (HSeO3-1 at physiological pH) across a plasma membrane.] |
|
vascular associated smooth muscle cell fate commitment
|
GO_0097081 |
[The commitment of cells to a vascular smooth muscle cell fate and their capacity to differentiate into vascular smooth muscle cells. A vascular smooth muscle cell is a non-striated, elongated, spindle-shaped cell found lining the blood vessels.] |
|
muscle cell fate commitment
|
GO_0042693 |
[The process in which the cellular identity of muscle cells is acquired and determined.] |
|
skeletal muscle regeneration at neuromuscular junction
|
GO_0014730 |
[The regrowth of muscle tissue to repair injured or damaged muscle fibers in the postnatal stage at the neuromuscular junction. Regeneration of neuromuscular junctions occurs in an orderly way and relies on communication between nerve and muscle. Skeletal myofibers regenerate after injury and form neuro-muscular junctions with motor axons similar to normal ones. Regenerating myofibers develop within the basal lamina sheaths (satellite cells) of original myofibers.] |
|
skeletal muscle tissue regeneration
|
GO_0043403 |
[The regrowth of skeletal muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.] |
|
spectrin-associated cytoskeleton
|
GO_0014731 |
[The part of the cytoskeleton composed of spectrin, protein 4.1 and ankyrin. Spectrin-associated cytoskeleton is associated with the plasma membrane.] |